Article
Genome-wide association studies (GWAS) in 2026: From gene hunting to biological discovery in endocrine and cardiometabolic diseases.
Annales d'endocrinologie - 1 May 2026
Berrandou Takiy-Eddine
Abstract excerpt
BACKGROUND: Genome-wide association studies (GWAS) emerged with expectations borrowed from Mendelian genetics, creating a gap between what the method can and cannot deliver. This gap has fuelled both unwarranted dismissal and unwarranted enthusiasm. For endocrine clinicians, the confusion is consequential because GWAS and clinical sequencing answer fundamentally different questions and serve different purposes....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.